News

Since 2015, when the National Institutes of Health awarded UB the Clinical and Translational Science Award (CTSA), clinical trial research has significantly expanded. That expansion has brought with it a stronger emphasis on using new approaches, both high-tech and low-tech, to bring cutting-edge health care to more Western New Yorkers.

A comprehensive, university-wide effort to boost clinical research at UB is paying off. Since 2015, the university has increased by more than 30 percent the funding it receives to conduct clinical trials supported by both the federal government and private industry.

Scientists have made spectacular progress in understanding human disease, but the rate that new treatments are getting to patients hasn’t improved.

A paper published this summer in the Journal of Clinical and Translational Science marked the culmination of a two-year collaboration between four universities that’s being called a model of multi-site, team-based translational science.

The Primary Care Research Institute currently has an opening in its T32 National Research Service Award (NRSA) fellowship program. This T32 fellowship prepares primary care research (PCR) fellows (both health professional and research-related doctorates) with PCR skills, emphasizing the Triple Aim research agenda. 

A paper published by a team of UB researchers in the July edition of the Journal of Clinical Microbiology has been picked up by two publications targeted to health care professionals. 

Eduardo Salas, PhD, is an internationally recognized expert on the science of teamwork, fostering team effectiveness and the design and implementation of team training strategies.